| ۲۱ | Differential tumor inhibitory effects induced by HER3 extracellular subdomain-specific mouse monoclonal antibodies | Hassani, D., Jeddi-Tehrani, M., Yousefi, P., (...), Amiri, M.M., Shokri, F. | Cancer Chemotherapy and Pharmacology | 2022 |
| ۲۲ | Identification of immunodominant epitopes on nucleocapsid and spike proteins of the SARS-CoV-2 in Iranian COVID-19 patients | Maghsood, F., Shokri, M.-R., Jeddi-Tehrani, M., (...), Amiri, M.M., Shokri, F. | Pathogens and Disease, | 2022 |
| ۲۳ | Optimization of an Efficient Cell Culture Hepatitis B Infection System for Assessment of Hepatitis B Virus Neutralizing Monoclonal Antibodies | Sarvnaz, H., Asadi-Asadabad, S., Amiri, M.M., (...), Golsaz-Shirazi, F., Shokri, F. | Iranian Journal of Immunology | 2022 |
| ۲۴ | Nucleolin; A tumor associated antigen as a potential lung cancer biomarker | Ezzatifar, F., Rafiei, A., Jeddi-Tehrani, M. | Pathology Research and Practice | 2022 |
| ۲۵ | Detection of Novel Autoantibodies to Nucleolin's RNA-binding Domains as a Serum Tumor Biomarker Through ELISA | Ezzatifar, F., Rafiei, A., Valadan, R., Asgarian-Omran, H., Jeddi-Tehrani, M. | Iranian Journal of Allergy, Asthma and Immunology | 2022 |
| ۲۶ | Cloning, expression and characterization of a peptibody to deplete myeloid derived suppressor cells in a murine mammary carcinoma model | Ramezani-Ali Akbari, K., Khaki-Bakhtiarvand, V., Mahmoudian, J., (...), Jeddi-Tehrani, M., Shabani, M.... | Protein Expression and Purification | 2022 |
| ۲۷ | Myeloid-derived suppressor cells (MDSCs) depletion by cabozantinib improves the efficacy of anti-HER2 antibody-based immunotherapy in a 4T1-HER2 murine breast cancer model | Khaki Bakhtiarvand, V., Ramezani-Ali Akbari, K., Amir Jalali, S., (...), Shokri, F., Shabani, M. | International Immunopharmacology | 2022 |
| ۲۸ | Epitope mapping of severe acute respiratory syndrome coronavirus 2 neutralizing receptor binding domain-specific monoclonal antibodies | Maghsood, F., Amiri, M.M., Zarnani, A.-H., (...), Moog, C., Shokri, F. | Frontiers in Medicine | 2022 |
| ۲۹ | Potent synergistic anti-tumor activity of a novel humanized anti-HER2 antibody hersintuzumab in combination with trastuzumab in xenograft models | Shiravi, F., Mohammadi, M., Golsaz-Shirazi, F., (...), Amiri, M.M., Shokri, F. | Investigational New Drugs | 2021 |
| ۳۰ | Culture density of menstrual blood-derived stromal/stem cells determines the quality of t cell responses: An experimental study | Nikoo, S., Ebtekar, M., Jeddi-Tehrani, M., Bozorgmehr, M., Zarnani, A.-H. | International Journal of Reproductive BioMedicine | 2021 |
| ۳۱ | Adoptive cell therapy with induced regulatory T cells normalises the abortion rate in abortion-prone mice | Idali, F., Rezaii-Nia, S., Golshahi, H., (...), Zarnani, A.H., Jeddi-Tehrani, M. | Reproduction, Fertility and Development | 2021 |
| ۳۲ | A Novel Anti-HER2 Bispecific Antibody With Potent Tumor Inhibitory Effects In Vitro and In Vivo | Mohammadi, M., Jeddi-Tehrani, M., Golsaz-Shirazi, F., (...), Amiri, M.M., Shokri, F. | Frontiers in Immunology | 2021 |
| ۳۳ | Does Prior Immunization with Measles, Mumps, and Rubella Vaccines Affect the Antibody Response to COVID-19 Antigens? | Hassani, D., Amiri, M.M., Maghsood, F., (...), Zarnani, A.-H., Shokri, F. | Iranian Journal of Immunology | 2021 |
| ۳۴ | A novel tumor inhibitory hybridoma monoclonal antibody with dual specificity for HER3 and HER2 | Hassani, D., Amiri, M.M., Mohammadi, M., (...), Jeddi-Tehrani, M., Shokri, F. | Current Research in Translational Medicine | 2021 |
| ۳۵ | Influence of Pattern Recognition Receptor Ligands on Induction of Innate Immunity and Control of Hepatitis B Virus Infection | Asadi-Asadabad, S., Sarvnaz, H., Amiri, M.M., (...), Golsaz-Shirazi, F., Shokri, F. | Viral Immunology | 2021 |
| ۳۶ | Proteome profiling of human placenta reveals developmental stage-dependent alterations in protein signature | Khorami Sarvestani, S., Shojaeian, S., Vanaki, N., (...), Jeddi-Tehrani, M., Zarnani, A.-H. | Clinical Proteomics | 2021 |
| ۳۷ | Differential Antibody Response to SARS-CoV-2 Antigens in Recovered and Deceased Iranian COVID-19 Patients | Maghsood, F., Hassani, D., Salimi, V., (...), Amiri, M.M., Shokri, F. | Viral Immunology | 2021 |
| ۳۸ | Monoclonal antibody directed to the PilQ -PilA DSL region in Pseudomonas aeruginosa improves survival of infected mice with antibiotic combination | Zahedi bialvaei, A., Razavi, S., Notash Haghighat, F., (...), Jeddi-Tehrani, M., Irajian, G. | Microbial Pathogenesis | 2021 |
| ۳۹ | Neutralization of tetanus toxin by a novel chimeric monoclonal antibody | Ghotloo, S., Golsaz-Shirazi, F., Amiri, M.M., Jeddi-Tehrani, M., Shokri, F. | Toxicon | 2021 |
| ۴۰ | Inhibitory Effect of Polyclonal Antibodies Against HER3 Extracellular Subdomains on Breast Cancer Cell Lines | Mansouri-Fard, S., Ghaedi, M., Shokri, M.-R., (...), Amiri, M.M., Shokri, F. | Asian Pacific Journal of Cancer Prevention | 2020 |